Dr. Christian Steinebach

Young Investigator

Habilitand in Pharmaceutical Chemistry

Research Areas

  • Design and Synthesis of PROTACs
  • Medicinal Chemistry of E3 Ligase Ligands
  • Novel Chemically-Induced Proximity (CIP) Modalities
  • Assessment vof bRo5 Drugs by means of modern HPLC Methods
Avatar Steinebach

Dr. Christian Steinebach

Pharmazeutisches Institut

An der Immenburg 4

Bonn


Personal Information

  • Lecture "Arzneibuchanalytik"
  • Lecture Series "Aktuelle Themen der Molekularen Biomedizin "
  • Praktical Course "Organische Chemie"
  • Seminars "Organische Chemie"
  • Carl-Friedrich-Mohr-Preis University of Bonn (2015)
  • PhD Scholarship by BIGS-DrugS (2016)
  • Molecules/MDPI PhD Thesis Award (2020)
  • Bayer PhD Thesis Awards (2021)
  • FEBS Short-Term Fellowship (2022)
  • Deutsche Pharmazeutische Gesellschaft (DPhG)
  • Gesellschaft Deutscher Chemiker (GDCh)
  • Gesellschaft für Biochemie und Molekularbiologie (GBM)
  •  Argelander Research Grant, University of Bonn (2020):
    "Targeting the androgen receptor with PROTACs to investigate a possible link between TMPRSS2 Expression and SARS-CoV-2 host cell entry" (completed)
  • Argelander Starter Grant, University of Bonn (2021-2022):
    "Development of Keap1/Nrf2 modulators for targeted protein degradation" (completed)
  • GRK 2873, German Research Foundation (2023):
    "Project P1: Exploring the chemical space of cereblon ligands: an access to new PROTACs"
  • Fonds der chemischen Industrie e.V.: “Sachkostenzuschuss für den Hochschullehrernachwuchs” (2023)
  • Individual Research Grant STE 3140, German Research Foundation (2024):
    "Discovery of BCL-2-selective degraders for applications in hematological malignancies"

Wird geladen